Close Menu

QuantumDx CEO Elaine Warburton will become an Officer of the Order of the British Empire, the Newcastle, UK-based molecular diagnostics firm announced recently.

Warburton cofounded QuantumDx in 2008. The British biotechnology firm is developing several point-of-care tests on a number of platforms, including a nanowire array-based biosensor. QuantumDx said that Warburton is receiving the OBE in recognition of her work with QuantumDx and other healthcare-focused companies and initiatives.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.